Privately held Celtaxsys Inc said on Thursday a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.
from Reuters: Health https://ift.tt/2O79tmO
via
IFTTT
0 comments: